StonvexLoading…
StonvexStonvexStonvexCore line items from CPS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.74B | $2.73B | $2.82B | $2.53B |
Operating Income | $86.60M | $69.82M | $46.03M | $-105.00M |
Net Income | $-4.17M | $-78.75M | $-201.99M | $-215.38M |
EPS (Diluted) | $-0.23 | $-4.48 | $-11.64 | $-12.53 |
Total Assets | $1.83B | $1.73B | $1.87B | $1.96B |
Total Liabilities | $1.92B | $1.87B | $1.96B | $1.86B |
Cash & Equivalents | $191.70M | $170.03M | $154.80M | $186.88M |
Free Cash Flow OCF − CapEx | $16.25M | $25.87M | $36.53M | $-107.30M |
Shares Outstanding | 17.64M | 17.33M | 17.20M | 17.11M |